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Abstract
Recent years have seen a marked reduction in the mortality of
children with meningococcal disease in paediatric intensive care
units (PICU); the reasons for this improvement are multifactorial.
The mortality rates for critically ill children overall have improved
and reasons for this are probably increased centralisation of PICU
services and that fewer critically ill children are now looked after on
adult units. Specific treatment pathways for sepsis have improved
with the publication of clinical guidelines for children and initiatives
such as the Surviving Sepsis Campaign. There is a continuing
need to focus on the care delivered to children before reaching
PICU and to minimise the morbidity suffered by survivors of this
disease.
Meningococcal disease (MCD) continues to be the most
common infective cause of death in children. In this issue of
the journal, Maat et al. describe a paediatric intensive care
unit (PICU) based study describing their experience of
managing children with MCD (specifically, sepsis and purpura)
over an 18 year period [1]. They are in the unusual and
valuable position of having collected their data prospectively.
The authors found that survival of children presenting to their
unit with MCD correlated with year of admission indicating a
significant ongoing reduction in case fatality. Indeed, the
authors have not seen a single death in PICU from sepsis and
purpura on their unit since 2002. These findings reflect the
significant reduction in mortality seen in MCD in the UK and
elsewhere over recent years [2,3]. Maat and colleagues
attribute the improvement in outcome in part to changes in
PICU management and resuscitation practices, but the
reasons are undoubtedly multifactorial.
Over the last decade there has been a significant improve-
ment in mortality rates in PICU generally [4,5]. These trends
have been much more easily examined in the UK since the
establishment of the Paediatric Intensive Care Audit Network
(PICANet) in 2002; an audit database recording details of the
treatment of all critically ill children in NHS PICUs in England,
Wales and Scotland (Edinburgh).
There has also been a move towards increased centralisation
of PICU services with fewer critically ill children being treated
in adult units over recent years. This trend is founded on
studies such as that of Pearson who demonstrated an excess
mortality and a greater length of stay in a region of the UK
with decentralised PICU services compared to the
centralised service of Victoria, Australia [6]. Similar findings
have been demonstrated in the USA and the Netherlands [7].
There has been an improvement in the awareness, diagnosis
and management of patients with sepsis in emergency
departments and critical care units since the recent
publication of clinical practice guidelines for children with
severe sepsis by Carcillo [8] drawing together the evidence
of benefit from aggressive early fluid resuscitation and
inotrope therapy. We have also seen the launch of the
Surviving Sepsis Campaign with the publication of clinical
practice guidelines [9] and the evolution of sepsis ‘care
bundles’ which have improved mortality. A specific MCD
management algorithm was published in the UK in 1999; a
document which has been extensively distributed and utilised
throughout emergency departments and paediatric units and
which has been recently updated [10].
Maat et al. set out to study the epidemiology of sepsis and
purpura in children ‘referred to the PICU’ and acknowledge
that deaths prior to PICU admission are not addressed.
Changes in PICU practice may lead to an increase in these
‘hidden’ MCD deaths. In a highly centralised PICU system
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where highly equipped PICU teams travel over great
distances, often by air, a significant number of critically ill
children may receive early and prolonged care from a PICU
team in a referring hospital. If children such as these
succumb to their illness before returning to the central PICU,
then they may not contribute to published PICU mortality
figures. True population based studies of MCD mortality are
of crucial importance; a study of this kind carried out in the
USA found that MCD mortality rates increased from 1990 to
1997 and decreased from 1998 to 2002 [11].
Policies to reduce mortality in the UK have been designed to
raise awareness at every step of the patient journey. Public
awareness had been raised with the help of charities such as
the Meningitis Research Foundation highlighting the need for
parents to seek medical help early for children with a high
temperature and a non-blanching rash (identified using the
‘tumbler test’) and stressing the importance of receiving the
meningococcal serogroup C conjugate vaccine. In November
1999, the UK became the first country to incorporate this
vaccine into a national immunisation programme. Following
this, disease attack rates dropped in the vaccinated, carriage
rates dropped and the incidence declined among unvacci-
nated persons, suggesting the development of herd immunity.
A recent study has demonstrated that up to half of all children
presenting to hospital with MCD had previously been
discharged home following a primary care assessment [12].
Strategies to increase awareness in primary care have
targeted the recognition of presenting clinical features and
the administration of penicillin to children prior to transfer to
hospital [13].
Ninis et al. determined three factors that were independently
associated with an increased risk of death in children with
MCD after admission to the district hospital. These were
failure to be looked after by a paediatrician, failure of
sufficient supervision of junior staff, and failure of staff to
administer adequate inotropes [14]. The involvement of a
skilled multidisciplinary paediatric team in the resuscitation,
stabilisation and transfer of any critically ill child with sepsis is
paramount and if carried out well will lead to an improvement
in outcome [15].
Survivors of invasive disease may sustain permanent
sequelae, such as deafness, seizures, limb amputation or
tissue loss, chronic renal impairment and developmental
delay. Maat et al. did not examine morbidity in their large
cohort, which would have been clinically highly relevant; there
is little published data on changes in the rate of morbidity due
to MCD over recent years. As with clinical conditions such as
leukaemia, an improvement in overall mortality inevitably leads
to greater focus on the quality of life of survivors with survival
being at minimum cost rather than at any cost.
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